Literature DB >> 29950502

Brown-Vialetto-Van Laere syndrome: a novel diagnosis to a common presentation.

Qalab Abbas1, Sidra Kaleem Jafri1, Sidra Ishaque1, Arshalooz Jamila Rahman1.   

Abstract

Brown-Vialetto-Van Laere syndrome (BVVLS) or riboflavin transporter deficiency (OMIM 211530) is a rare treatable autosomal recessive neurodegenerative disorder. This condition is associated with progressive pontobulbar palsy. We describe the clinical course of a 16-month-old boy with BVVLS and a novel homozygous mutation from Pakistan. Our patient presented with stridor and respiratory insufficiency. Hearing loss which is the most common sign of this condition was absent, making it an unusual presentation of BVVLS. His examination revealed ptosis and tongue fasciculation. His riboflavin receptor mutational analysis showed the homozygous mutation in the SLC52A3 gene. Per oral riboflavin was administered, and subsequently, he was able to be weaned off the ventilator. Now the child is improving and attaining developmental milestones. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  mechanical ventilation; neuromuscular disease

Mesh:

Substances:

Year:  2018        PMID: 29950502      PMCID: PMC6040568          DOI: 10.1136/bcr-2018-224958

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Infantile progressive bulbar palsy with deafness.

Authors:  Konstantinos A Voudris; Angeliki Skardoutsou; Eleni A Vagiakou
Journal:  Brain Dev       Date:  2002-10       Impact factor: 1.961

2.  Brown-Vialetto-Van Laere syndrome; variability in age at onset and disease progression highlighting the phenotypic overlap with Fazio-Londe disease.

Authors:  Subrahmanian Dipti; Anne-Marie Childs; John H Livingston; A K Aggarwal; Mike Miller; Chris Williams; Yanick J Crow
Journal:  Brain Dev       Date:  2004-12-15       Impact factor: 1.961

Review 3.  Brown-Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders: 3 Cases From the Clinic and Review of the Literature.

Authors:  Tyler Allison; Inés Roncero; Rob Forsyth; Keith Coffman; Jean-Baptiste Le Pichon
Journal:  J Child Neurol       Date:  2017-01-24       Impact factor: 1.987

4.  Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van Laere disease: two novel mutations.

Authors:  Marianna Ciccolella; Stefania Corti; Michela Catteruccia; Stefania Petrini; Giulia Tozzi; Teresa Rizza; Rosalba Carrozzo; Monica Nizzardo; Andreina Bordoni; Dario Ronchi; Adele D'Amico; Cristiano Rizzo; Giacomo Pietro Comi; Enrico Bertini
Journal:  J Med Genet       Date:  2012-12-14       Impact factor: 6.318

5.  Brown-Vialetto-Van Laere syndrome: clinical and neuropathologic findings with immunohistochemistry for C20orf54 in three affected patients.

Authors:  Patrick Malafronte; H Brent Clark; Irene Castaneda-Sanchez; Jack Raisanen; Kimmo J Hatanpaa
Journal:  Pediatr Dev Pathol       Date:  2013-05-20

6.  The First Case of Riboflavin Transporter Deficiency in sub-Saharan Africa.

Authors:  Shaakira Chaya; Marco Zampoli; Diane Gray; Jane Booth; Gillian Riordan; Alvin Ndondo; Karen Fieggen; Jody Rusch; George van der Watt; Komala Pillay; Francois van der Westhuizen; Manoj Menezes; Jo Wilmshurst
Journal:  Semin Pediatr Neurol       Date:  2017-04-04       Impact factor: 1.636

7.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.

Authors:  Peter Green; Matthew Wiseman; Yanick J Crow; Henry Houlden; Shelley Riphagen; Jean-Pierre Lin; F Lucy Raymond; Anne-Marie Childs; Eamonn Sheridan; Sian Edwards; Dragana J Josifova
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

Review 8.  The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives.

Authors:  Annet M Bosch; Kevin Stroek; Nico G Abeling; Hans R Waterham; Lodewijk Ijlst; Ronald J A Wanders
Journal:  Orphanet J Rare Dis       Date:  2012-10-29       Impact factor: 4.123

Review 9.  Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.

Authors:  Bregje Jaeger; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2016-03-14       Impact factor: 4.982

10.  Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.

Authors:  Andreea Manole; Zane Jaunmuktane; Iain Hargreaves; Marthe H R Ludtmann; Vincenzo Salpietro; Oscar D Bello; Simon Pope; Amelie Pandraud; Alejandro Horga; Renata S Scalco; Abi Li; Balasubramaniem Ashokkumar; Charles M Lourenço; Simon Heales; Rita Horvath; Patrick F Chinnery; Camilo Toro; Andrew B Singleton; Thomas S Jacques; Andrey Y Abramov; Francesco Muntoni; Michael G Hanna; Mary M Reilly; Tamas Revesz; Dimitri M Kullmann; James E C Jepson; Henry Houlden
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501

View more
  1 in total

Review 1.  Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy.

Authors:  Maria Tolomeo; Alessia Nisco; Piero Leone; Maria Barile
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.